Case closed: Neutrons settle 40-year debate on enzyme for drug design
Filter News
Area of Research
- (-) Computational Biology (1)
- Advanced Manufacturing (2)
- Biology and Environment (32)
- Clean Energy (19)
- Electricity and Smart Grid (1)
- Functional Materials for Energy (1)
- Fusion and Fission (4)
- Materials (34)
- Materials for Computing (6)
- National Security (6)
- Neutron Science (102)
- Nuclear Science and Technology (5)
- Supercomputing (30)
News Type
Date
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.